Project Grant HT94252310384
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$750K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
The Washington University Office of Sponsored Research Services Division was awarded a $1,377,119 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct the study "AD GENETIC RISK AS A PROGNOSTIC FACTOR FOR COGNITIVE OUTCOMES AFTER TBI" over a 4-year period from September 2024 to September 2028. This federal grant supports innovative biomedical research aimed at improving health outcomes for military service...
The Defense Health Agency awarded a $7,999,917 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Research Foundation For The State University Of New York on behalf of Suny Downstate Health Sciences University. The four-year award beginning September 30, 2022 supports the "GAP-BASED MILIEU BIOMARKERS FOR TRAUMATIC BRAIN INJURY (GAMBIT-TBI)" program. Under the award, Suny Downstate and six sub-awardees - The Morehouse School Of Medicine, Inc.,...
This $6,214,900 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the Scintillon Institute to investigate the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The 4-year award, effective from November 1, 2024 to October 31, 2028, will enable the Scintillon Institute to conduct advanced biomedical research...
This $1,857,850 Cooperative Agreement was awarded by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The award supports a research project titled "Activation of Latent TGF-Beta as a Novel Anti-Inflammatory Treatment for Traumatic Brain Injury (TBI)" that aims to investigate the potential of the protein PSG1 to...
This Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, provides $999,965.00 to Yale University to conduct research targeting the TDP-43 protein dynamics associated with trauma-induced Alzheimer's disease-related dementia. The research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to the prevention, diagnosis, and treatment of...
The Defense Health Agency awarded a $749,905 Project Grant to The Roskamp Institute Inc. under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to investigate microglial NOX2/NLRP3 inflammasome activation and its role in driving tau pathology and cognitive impairments in chronic traumatic brain injury. Specifically, the Roskamp Institute will conduct basic, applied, and advanced biomedical...
This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...
This federal Project Grant award of $822,501.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research by The Trustees of Columbia University in the City of New York to investigate "Restoring GABAergic Inhibition as a Potential Therapy for TSC-Associated Neurocognitive Impairment". The research project aims to explore innovative approaches to address neurocognitive issues associated with tuberous sclerosis...
The Department of the Army Medical Command awarded Tufts University School of Medicine a $813,375 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to investigate metabolic modulation of collagens in the extracellular matrix to preserve GABAergic inhibition after traumatic brain injury. The three-year award beginning August 1, 2022 will support research into medical solutions for traumatic brain injuries sustained on the battlefield. A $813k sub-award...